A Trial of Antroquinonol in Patients With Atopic Dermatitis

Summary

This is a multi-centers, phase IIa, double blind, randomized, placebo-controlled trial of Antroquinonol in patients with atopic dermatitis.Duration of treatment is 12 week in total. Study visits will occur every 4 weeks. AEs/SAEs, changes to concomitant medications will be noted, vital signs will be taken, and efficacy evaluations will be performed as well. The last estimation of variable scores will occur for all subjects.

Timeline

Start

2018-07-17

Primary completion

2019-07-09

Completion

2019-07-09

Drugs

Indications